ATE467411T1 - Retinoidlösungen und formulierungen daraus - Google Patents

Retinoidlösungen und formulierungen daraus

Info

Publication number
ATE467411T1
ATE467411T1 AT05826137T AT05826137T ATE467411T1 AT E467411 T1 ATE467411 T1 AT E467411T1 AT 05826137 T AT05826137 T AT 05826137T AT 05826137 T AT05826137 T AT 05826137T AT E467411 T1 ATE467411 T1 AT E467411T1
Authority
AT
Austria
Prior art keywords
retinoid
formulations
completely
solubilized
retinoid solutions
Prior art date
Application number
AT05826137T
Other languages
English (en)
Inventor
Mohan Vishnupad
Naomi Vishnupad
Original Assignee
Imaginative Res Associates Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/984,630 external-priority patent/US7662855B2/en
Application filed by Imaginative Res Associates Inc filed Critical Imaginative Res Associates Inc
Application granted granted Critical
Publication of ATE467411T1 publication Critical patent/ATE467411T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT05826137T 2004-11-09 2005-11-09 Retinoidlösungen und formulierungen daraus ATE467411T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/984,630 US7662855B2 (en) 2004-05-11 2004-11-09 Retinoid solutions and formulations made therefrom
US13287705A 2005-05-19 2005-05-19
PCT/US2005/040510 WO2006053006A2 (en) 2004-11-09 2005-11-09 Retinoid solutions and formulations made therefrom

Publications (1)

Publication Number Publication Date
ATE467411T1 true ATE467411T1 (de) 2010-05-15

Family

ID=36190667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05826137T ATE467411T1 (de) 2004-11-09 2005-11-09 Retinoidlösungen und formulierungen daraus

Country Status (9)

Country Link
EP (2) EP1809244B1 (de)
JP (1) JP2008519764A (de)
AT (1) ATE467411T1 (de)
BR (1) BRPI0517684A (de)
CA (1) CA2586798A1 (de)
DE (1) DE602005021238D1 (de)
ES (1) ES2344214T3 (de)
MX (1) MX2007005449A (de)
WO (1) WO2006053006A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018154145A2 (en) * 2018-03-29 2018-08-30 Symrise Ag Compounds for skin improvement / treatment

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275222A (en) 1978-10-10 1981-06-23 Finetex, Inc. Benzoate ester compositions
US4278655A (en) 1979-03-07 1981-07-14 Finetex, Inc. Antiperspirant composition
US4293544A (en) 1979-03-07 1981-10-06 Finetex Incorporated Fluid and semi-fluid compositions including benzoate esters
US4322545A (en) 1979-09-14 1982-03-30 Finetex, Inc. Benzoic acid esters
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
US4323694A (en) 1981-04-13 1982-04-06 Finetex, Inc. Benzoic acid esters
US5721275A (en) 1989-06-07 1998-02-24 Bazzano; Gail S. Slow release vehicles for minimizing skin irritancy of topical compositions
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
EP0706370B2 (de) * 1993-07-01 2005-01-26 Yamanouchi Europe B.V. Verwendung von nicht-ionischen oberflachenaktiven substanzen in retinoid enthaltenden stabilen topischen zusammensetzungen
FR2710841B1 (fr) * 1993-10-05 1995-11-17 Oreal Composition cosmétique ou pharmaceutique pour la peau, anhydre et stable, à base de rétinol et son utilisation en vue du traitement des maladies de la peau.
US5632996A (en) 1995-04-14 1997-05-27 Imaginative Research Associates, Inc. Benzoyl peroxide and benzoate ester containing compositions suitable for contact with skin
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
AU2001233174A1 (en) * 2000-01-31 2001-08-07 Engelhard Corporation Surfactant free topical compositions and method for rapid preparation thereof
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
JP4400705B2 (ja) * 2002-03-29 2010-01-20 株式会社タニ 内容物の混合構造を有する包装容器
US20030215493A1 (en) * 2002-04-30 2003-11-20 Patel Pravin M. Composition and method for dermatological treatment
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
US7662855B2 (en) * 2004-05-11 2010-02-16 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom

Also Published As

Publication number Publication date
JP2008519764A (ja) 2008-06-12
MX2007005449A (es) 2007-12-07
EP1809244B1 (de) 2010-05-12
DE602005021238D1 (de) 2010-06-24
WO2006053006A9 (en) 2006-07-27
WO2006053006A2 (en) 2006-05-18
WO2006053006A3 (en) 2006-09-08
BRPI0517684A (pt) 2008-10-14
ES2344214T3 (es) 2010-08-20
EP1809244A2 (de) 2007-07-25
CA2586798A1 (en) 2006-05-18
EP2145618A1 (de) 2010-01-20

Similar Documents

Publication Publication Date Title
Suschek et al. The application of cold atmospheric plasma in medicine: The potential role of nitric oxide in plasma-induced effects
Daniels et al. Galenics of dermal products–vehicles, properties and drug release
ES2275948T3 (es) Un gel que contiene al menos un retinoide y un peroxido de benzoilo.
JP5465011B2 (ja) 少なくとも1種のレチノイドおよび過酸化ベンゾイルを含むエマルジョン
ES2539655T3 (es) Composición cosmética líquida que comprende un monoalcohol
CA2455983A1 (en) Preservative systems and their use in cosmetic preparations
Rozman et al. Stability of vitamins C and E in topical microemulsions for combined antioxidant therapy
AU2013269583B2 (en) Oil/water-emulsion-type topical compositions containing a retinoid
BR0307898A (pt) Formulações de droga antibiótica oftálmica contendo um composto de ciclodextrina e cloreto de cetil piridìnio
AR056808A1 (es) Formulacion de aceite en agua de avermectinas
US8337870B2 (en) Low toxicity topical active agent delivery system
AR080368A1 (es) Disoluciones acuosas transparentes de acetonido de fluocinolona para el tratamiento de la inflamacion de oido
Farahmand et al. Formulation and evaluation of a vitamin C multiple emulsion
US20230081357A1 (en) Topical composition comprising cannabidiol
CA2917737A1 (en) Transparent sunscreen compositions and use thereof
US20150320867A1 (en) Topical formulations and methods for the use thereof
ES2307566T3 (es) Composiciones estables para el cuidado de la piel que contienen un retinoide y un sistema reforzador del retinoide.
JP7095086B2 (ja) 4-(3-アルコキシ-4-ヒドロキシフェニル)アルキルケトンを含む2相化粧用組成物
ATE467411T1 (de) Retinoidlösungen und formulierungen daraus
CN104887562A (zh) 一种具有阻断黑色素功能的美白祛斑霜
JP2004527471A (ja) レチノイドブースターを含有する安定な皮膚コンディショニング組成物
ES2125428T3 (es) Composicion fundente que contiene sales de amonio cuaternario con funcion ester, su utilizacion como producto capilar.
ES2173112T3 (es) Formulacion ectoparasiticida.
NZ521533A (en) Veterinary compositions for the treatment of parasitic diseases containing rafoxanide
Lawson Nano Drug Delivery Formulations for Topical Dermal Administration of L-Ascorbic Acid and Derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties